Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Journal of Medical Biography|March 4, 2014
Discovery of why acute lymphoblastic leukaemia cells are killed by asparaginase: Adventures of a young post-doctoral student, Bertha K MadrasPhilip Seeman
ACS Chemical Neuroscience|November 14, 2013
Clozapine, a fast-off-D2 antipsychoticPhilip Seeman
Journal of Clinical Psychopharmacology|February 21, 2013
Comment on: "Adverse events in healthy subjects exposed to single and multiple doses of LY2140023 monohydrate" by Ayan-Oshodi et al (J Clin Psychopharmacol 2012;32[3]:408-411)Philip Seeman
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 18, 2013
Schizophrenia and dopamine receptorsPhilip Seeman
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 25, 2013
Are dopamine D2 receptors out of control in psychosis?Philip Seeman
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 5, 2002
Atypical antipsychotics: mechanism of actionPhilip Seeman
Synapse (New York, N.Y.)|December 17, 2008
Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animalsPhilip Seeman
Psychiatry Research|October 15, 2013
Schizophrenia thalamus imaging: low benzamide binding to dopamine D2 receptors suggests fewer D2Short receptors and fewer presynaptic terminalsPhilip Seeman
Synapse (New York, N.Y.)|September 14, 2007
Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptorsPhilip Seeman
Synapse (New York, N.Y.)|September 29, 2011
Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scansPhilip Seeman
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Journal of Medical Biography|March 4, 2014
Discovery of why acute lymphoblastic leukaemia cells are killed by asparaginase: Adventures of a young post-doctoral student, Bertha K MadrasPhilip Seeman
ACS Chemical Neuroscience|November 14, 2013
Clozapine, a fast-off-D2 antipsychoticPhilip Seeman
Journal of Clinical Psychopharmacology|February 21, 2013
Comment on: "Adverse events in healthy subjects exposed to single and multiple doses of LY2140023 monohydrate" by Ayan-Oshodi et al (J Clin Psychopharmacol 2012;32[3]:408-411)Philip Seeman
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 18, 2013
Schizophrenia and dopamine receptorsPhilip Seeman
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 25, 2013
Are dopamine D2 receptors out of control in psychosis?Philip Seeman
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 5, 2002
Atypical antipsychotics: mechanism of actionPhilip Seeman
Synapse (New York, N.Y.)|December 17, 2008
Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animalsPhilip Seeman
Psychiatry Research|October 15, 2013
Schizophrenia thalamus imaging: low benzamide binding to dopamine D2 receptors suggests fewer D2Short receptors and fewer presynaptic terminalsPhilip Seeman
Synapse (New York, N.Y.)|September 14, 2007
Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptorsPhilip Seeman
Synapse (New York, N.Y.)|September 29, 2011
Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scansPhilip Seeman
Pageof 11